Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Azacitidine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 179 Myelodysplastic Syndromes 76 Leukemia 38 Leukemia, Myelomonocytic, Chronic 31 Recurrence 14 Myeloproliferative Disorders 12 Neoplasm, Residual 9 Leukemia, Biphenotypic, Acute 9 Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, T-Cell, Peripheral 7 Anemia, Refractory, with Excess of Blasts 7 Myelodysplastic-Myeloproliferative Diseases 6 Lymphoma, Non-Hodgkin 6 Primary Myelofibrosis 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Hodgkin Disease 5 Hematologic Neoplasms 5 Congenital Abnormalities 5 Multiple Myeloma 4 Lymphoma, T-Cell 4 Lymphoma, Follicular 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Polycythemia Vera 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Radiosurgery 99 Temozolomide 86 Bevacizumab 60 Magnetic Resonance Spectroscopy 59 Radiotherapy 52 Carboplatin 27 pembrolizumab 26 Irinotecan 22 Nivolumab 21 Surgical Procedures, Operative 20 Magnetic Resonance Imaging 19 Etoposide 19 Surveys and Questionnaires 18 Ipilimumab 18 Cyclophosphamide 18 Radiation 17 Erlotinib Hydrochloride 17 Aminolevulinic Acid 17 Specimen Handling 15 Pemetrexed 15 Cisplatin 13 Carmustine 13 Neuropsychological Tests 12 Mental Status and Dementia Tests 12 Topotecan 11 Filgrastim 10 Drug Therapy 10 Dexmedetomidine 10 Capecitabine 10 Trastuzumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02940483 2018-11-30

5-AZA

The University of Texas Health Science Center, Houston

Phase EARLY_PHASE1 Completed

Brain Neoplasms, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡